Diamyd Medical Announces First Meeting With FDA To Discuss Type 1 Diabetes Clinical Program In The US

... Diamyd Medical AB (SWEDEN NOMX: DIAM B; US ADR: DMYDY) announced today that it is submitting a Pre-IND/ End of Phase II Briefing Package with the United States Food and Drug Administration relating to a proposed type 1 diabetes clinical trial in the US. The Briefing Package is submitted in support of a meeting with the agency scheduled for January 29, 2007 in Washington DC. [click link for full article] ...